Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eribulin vs Dacarbazine in Advanced Soft Tissue Sarcoma
NCT01327885Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Mar 2011
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 23
01
Overview
A Phase 3 trial of eribulin in soft tissue sarcoma (STS), sponsored by Eisai Co., Ltd.. Started Mar 2011; status: completed.
02
Drugs
eribulin
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT01327885.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01327885.